Filing Details
- Accession Number:
- 0001209191-18-005679
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-26 17:53:43
- Reporting Period:
- 2018-01-24
- Accepted Time:
- 2018-01-26 17:53:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1346830 | Cara Therapeutics Inc. | CARA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1597152 | Ph.d. Frederique Menzaghi | C/O Cara Therapeutics, Inc. 107 Elm Street, 9Th Floor Stamford CT 06902 | Sr Vp-Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-01-24 | 15,000 | $15.00 | 122,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2017.
Billionaire Hedge Funds
